Supernus (SUPN) Reports Q4 Earnings: What Key Metrics Have to Say
https://www.zacks.com/stock/news/2232821/supernus-supn-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2232821
Feb 27, 2024 - Although the revenue and EPS for Supernus (SUPN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for
https://www.zacks.com/stock/news/2228591/analysts-estimate-supernus-pharmaceuticals-supn-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2228591
Feb 20, 2024 - Supernus (SUPN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Pages: 1
Page 1